CRISPR: CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $38.54, denoting a -1.76% change from the preceding trading day.
Read full article »
CRISPR is a gene-editing company that develops and commercializes gene-based medicines for the treatment of serious diseases.
Read more